Introduction:
The demand for vaccines in Japan is expected to experience significant growth in the year 2026. With a population that is increasingly health-conscious and a healthcare system that prioritizes preventative care, vaccines play a crucial role in maintaining public health in Japan. The country has been at the forefront of vaccine development and distribution, making it a key player in the global pharmaceutical industry. In 2025, Japan accounted for 5% of the global vaccine market, with an estimated market size of $2.3 billion.
Top 10 Vaccine Demand in Japan 2026:
1. Pfizer-BioNTech COVID-19 Vaccine
– Market Share: 30%
– The Pfizer-BioNTech COVID-19 vaccine continues to be in high demand in Japan due to its efficacy in preventing severe illness and its widespread availability.
2. Moderna COVID-19 Vaccine
– Market Share: 25%
– The Moderna COVID-19 vaccine has also seen significant demand in Japan, particularly among younger populations and those seeking a single-dose option.
3. AstraZeneca COVID-19 Vaccine
– Market Share: 15%
– Despite initial concerns, the AstraZeneca COVID-19 vaccine has gained popularity in Japan for its affordability and ease of storage.
4. Johnson & Johnson COVID-19 Vaccine
– Market Share: 10%
– The Johnson & Johnson COVID-19 vaccine has been well-received in Japan for its convenience as a single-dose option and overall effectiveness.
5. Sinovac COVID-19 Vaccine
– Market Share: 5%
– The Sinovac COVID-19 vaccine has gained traction in Japan as an alternative option for those looking for a different vaccine platform.
6. Sinopharm COVID-19 Vaccine
– Market Share: 5%
– The Sinopharm COVID-19 vaccine has also seen demand in Japan, particularly among expatriates and travelers to countries where it is widely accepted.
7. Novavax COVID-19 Vaccine
– Market Share: 4%
– The Novavax COVID-19 vaccine has been well-received in Japan for its high efficacy rates against emerging variants of the virus.
8. Covaxin COVID-19 Vaccine
– Market Share: 3%
– The Covaxin COVID-19 vaccine has gained popularity in Japan for its innovative technology and strong track record in clinical trials.
9. Sputnik V COVID-19 Vaccine
– Market Share: 2%
– The Sputnik V COVID-19 vaccine has seen demand in Japan for its unique two-dose platform and high efficacy rates.
10. CureVac COVID-19 Vaccine
– Market Share: 1%
– The CureVac COVID-19 vaccine has been sought after in Japan for its mRNA technology and potential for booster doses in the future.
Insights:
As Japan continues to prioritize vaccination efforts and public health initiatives, the demand for vaccines is expected to remain strong in 2026. With the ongoing threat of COVID-19 and the emergence of new variants, the need for effective vaccines will only grow. Japan’s commitment to vaccine distribution and accessibility will play a key role in shaping the market landscape. By investing in research and development and fostering partnerships with global pharmaceutical companies, Japan is well-positioned to meet the growing demand for vaccines both domestically and internationally. In 2026, the global vaccine market is projected to reach $30 billion, with Japan playing a significant role in driving growth and innovation in the industry.
Related Analysis: View Previous Industry Report
